STOCK TITAN

Amprius Technologies (NYSE: AMPX) insider plans more stock sales

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Amprius Technologies, Inc. (symbol AMPX) is named as the issuer in a notice filed by insider Thomas M. Stepien to sell company common stock under Rule 144. The planned transaction involves 8,000 shares of common stock held at Morgan Stanley Smith Barney LLC, relating to restricted stock that vests on August 20, 2026 under a registered plan, with the issuer listed as Amprius and the consideration described as services rendered.

Over the prior three months, Thomas M. Stepien reported additional sales of Amprius common stock: 23,529 shares for $243,312.64 on August 20, 2026; 2,000 shares for $41,940.00 on June 4, 2026; and 4,375 shares for $75,221.56 on May 27, 2026.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 8,000 shares of common stock Planned Rule 144 sale related to restricted stock vesting on August 20, 2026
Recent sale on August 20, 2026 23,529 shares for $243,312.64 Sale of Amprius common stock by Thomas M. Stepien
Sale on June 4, 2026 2,000 shares for $41,940.00 Sale of Amprius common stock by Thomas M. Stepien
Sale on May 27, 2026 4,375 shares for $75,221.56 Sale of Amprius common stock by Thomas M. Stepien
Vesting date of restricted stock August 20, 2026 Restricted stock vesting under a registered plan related to the 8,000 shares
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Restricted Stock Vesting Under a Registered Plan"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Registered Plan financial
"Restricted Stock Vesting Under a Registered Plan"
A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.

FAQ

What insider transaction does this Form 144 report for AMPX?

The notice reports that Thomas M. Stepien plans to sell 8,000 shares of Amprius Technologies, Inc. common stock under Rule 144, related to restricted stock vesting on August 20, 2026 under a registered plan, with consideration described as services rendered.

How many AMPX shares is Thomas M. Stepien planning to sell in this filing?

Thomas M. Stepien is planning to sell 8,000 shares of Amprius Technologies, Inc. common stock. These shares are associated with restricted stock vesting under a registered plan on August 20, 2026, with the issuer listed as Amprius and consideration noted as services rendered.

What AMPX insider sales were made by Thomas M. Stepien in the past three months?

Over the past three months, Thomas M. Stepien reported selling 23,529 shares for $243,312.64 on August 20, 2026; 2,000 shares for $41,940.00 on June 4, 2026; and 4,375 shares for $75,221.56 on May 27, 2026.

Which broker is handling the planned AMPX share sale in this Form 144?

The planned sale of 8,000 Amprius Technologies, Inc. shares is indicated as being handled through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What type of AMPX securities are involved in this Form 144 filing?

The filing concerns common stock of Amprius Technologies, Inc. The 8,000 shares to be sold arise from restricted stock vesting on August 20, 2026 under a registered plan, with consideration identified as services rendered to the issuer.

What is the aggregate value associated with the recent AMPX insider sales reported?

Recent reported sales by Thomas M. Stepien include $243,312.64 on 23,529 shares, $41,940.00 on 2,000 shares, and $75,221.56 on 4,375 shares of Amprius Technologies, Inc. common stock over the three-month period covered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature